Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Orion Pharma Aktiebolag
AB
Active
Org 5561936294
Golfvägen 2, 182 31
Danderyd
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 1976
50-99 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Orion Pharma Aktiebolag
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (4)
JO
Jesper Otto Qvist-Pedersen
Chief Executive Officer
Chief Executive Officer
2020
JE
Jon Engeseth
External Signatory
External Signatory
2020
AJ
Anders Joakim Toivo Taaler
Chief Auditor
Chief Auditor
2022
PM
Per Magnus Bertil Ebeling
External Signatory
External Signatory
2020
Former (1)
RH
Resul Hamurcu
Chief Auditor
Chief Auditor
2020 – 2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
RK
René Kristian Lindell
Board of Directors
2024
MK
Mikko Kemppainen
Board of Directors
2025
SM
Satu Maarit Ahomäki
Chairman
2020
Former (2)
OH
Olli Heikki Huotari
Board of Directors
2020 – 2025
JK
Jari Karlsson
Board of Directors
2020 – 2024
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
ORION CORPORATION
Company
100%
100%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Orion Pharma Aktiebolag
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
